ECKERT & ZIEGLER BEBIG GmbH

Eckert & Ziegler SE is a leading global provider of isotope technology for medical, scientific, and industrial applications. Headquartered in Berlin and listed on the Frankfurt Stock Exchange (TecDAX), the company specializes in cancer therapy, nuclear-medical imaging, and industrial radiometry. With approximately 1,143 employees, Eckert & Ziegler manufactures pharmaceutical-grade radioactive ingredients for cancer treatment and diagnosis. The company's core competencies include radiopharmaceutical synthesis, brachytherapy sources, hot cell solutions, and radiosynthesis technology. Its medical products segment delivers radioactive compounds for oncology and diagnostic imaging, while the isotope products segment manufactures radiation sources for medical and industrial applications. Eckert & Ziegler also develops quality control instruments and theranostic solutions, including specialized products such as Lutetium-177. The company has achieved significant market presence across Europe and North America through strategic acquisitions and partnerships.